Micro-X Limited (ASX:MX1)
Australia · Delayed Price · Currency is AUD 0.0650
-0.0050 (-7.14%)
Feb 26, 2026, 3:25 PM AEST
Micro-X Revenue
In the fiscal year ending June 30, 2025, Micro-X had annual revenue of 13.05M AUD, down -14.25%. Micro-X had revenue of 5.65M in the half year ending June 30, 2025, a decrease of -18.98%.
Revenue
13.05M
Revenue Growth
-14.25%
P/S Ratio
3.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 13.05M | -2.17M | -14.25% |
| Jun 30, 2024 | 15.22M | 217.00K | 1.45% |
| Jun 30, 2023 | 15.01M | 6.04M | 67.28% |
| Jun 30, 2022 | 8.97M | 5.20M | 137.87% |
| Jun 30, 2021 | 3.77M | -480.00K | -11.29% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SomnoMed | 111.49M |
| Compumedics | 51.04M |
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| ImpediMed | 12.72M |
| CurveBeam AI | 12.10M |
| Control Bionics | 6.14M |
| CONNEQT Health | 6.05M |
Micro-X News
- 3 months ago - Micro-X Limited (MCRXF) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 4 months ago - Micro-X Limited (MCRXF) Q1 2026 Earnings Call Transcript - Seeking Alpha